1. What is Onglyza?
- Onglyza is a medication used to help control high blood sugar in people with Type 2 diabetes who do not suffer from diabetic ketoacidosis.
2. Who is the manufacturer of Onglyza?
- Onglyza is manufactured by AstraZeneca
3. Is Onglyza approved by the FDA?
- Yes. Onglyza was approved by the FDA in 2009.
4. How does Onglyza work?
- Onglyza belongs to a class of drugs known as DPP-4 inhibitors. This DPP-4 inhibitor is an incretin-based therapy that helps the pancreas secrete more insulin and stop the liver from making excess sugar.
5. What are the complications associated with taking Onglyza?
- Onglyza can cause an array of side effects, some benign and some very serious.
- The more common side effects include:
- Nausea and vomiting
- Sore throat
- Stuffy or runny nose
- Low blood sugar
- Swelling or fluid retention.
- More serious complications include:
- Heart complications, including heart failure
- Pancreatic cancer
- Thyroid cancer
- Bladder cancer
6. Why are lawsuits being filed by consumers?
- Lawsuits are being filed against the manufacturer of Onglyza because of the serious complications the medication can cause and the lack of a proper warning of those complications.
7. Where can I go for help?
- If you or a loved one has taken Onglyza and suffered heart failure and/or death, you may have a case for compensation against AstraZeneca. At Reich & Binstock, we are here to help. Contact our lawyers for a free and confidential case evaluation. Call 1-866-LAW-2400 or complete the contact form on this website.